Moshe Alafi - Net Worth and Insider Trading

Moshe Alafi Net Worth

The estimated net worth of Moshe Alafi is at least $257 Million dollars as of 2024-05-10. Moshe Alafi is the 10% Owner of Intra-Cellular Therapies Inc and owns about 3,953,270 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $257 Million. Details can be seen in Moshe Alafi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Moshe Alafi has not made any transactions after 2017-10-02 and currently still holds the listed stock(s).

Transaction Summary of Moshe Alafi

To

Moshe Alafi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Moshe Alafi owns 2 companies in total, including Intra-Cellular Therapies Inc (ITCI) , and Stereotaxis Inc (STXS) .

Click here to see the complete history of Moshe Alafi’s form 4 insider trades.

Insider Ownership Summary of Moshe Alafi

Ticker Comapny Transaction Date Type of Owner
ITCI Intra-Cellular Therapies Inc 2017-10-02 10 percent owner
STXS Stereotaxis Inc 2004-08-11 10 percent owner

Moshe Alafi Latest Holdings Summary

Moshe Alafi currently owns a total of 1 stock. Moshe Alafi owns 3,953,270 shares of Intra-Cellular Therapies Inc (ITCI) as of October 2, 2017, with a value of $257 Million.

Latest Holdings of Moshe Alafi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ITCI Intra-Cellular Therapies Inc 2017-10-02 3,953,270 64.96 256,804,419

Holding Weightings of Moshe Alafi


Moshe Alafi Form 4 Trading Tracker

According to the SEC Form 4 filings, Moshe Alafi has made a total of 0 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years. The most-recent trade in Intra-Cellular Therapies Inc is the acquisition of 258,065 shares on October 2, 2017, which cost Moshe Alafi around $4 Million.

Insider Trading History of Moshe Alafi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Moshe Alafi Trading Performance

GuruFocus tracks the stock performance after each of Moshe Alafi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Moshe Alafi is -7.52%. GuruFocus also compares Moshe Alafi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Moshe Alafi within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Moshe Alafi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Moshe Alafi

Average Return

Average return per transaction

Outperforming Transactions

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.65
Relative Return to S&P 500(%) -0.92

Moshe Alafi Ownership Network

Ownership Network List of Moshe Alafi

No Data

Ownership Network Relation of Moshe Alafi


Moshe Alafi Owned Company Details

What does Intra-Cellular Therapies Inc do?

Who are the key executives at Intra-Cellular Therapies Inc?

Moshe Alafi is the 10 percent owner of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include Chief Medical Officer Suresh K. Durgam , EVP & Chief Commercial Officer Mark Neumann , and VP of Finance & CFO & Secretary Lawrence J. Hineline .

Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary

Over the past 18 months, Moshe Alafi made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 181,034 shares made by Mark Neumann , a net sale of 554,970 shares made by Sharon Mates , and a net sale of 233,341 shares made by Michael Halstead .

In summary, during the past 3 months, insiders sold 237,827 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 237,827 shares. During the past 18 months, 1,382,842 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,382,842 shares.

Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intra-Cellular Therapies Inc Insider Transactions

No Available Data

Moshe Alafi Mailing Address

Above is the net worth, insider trading, and ownership report for Moshe Alafi. You might contact Moshe Alafi via mailing address: 1311 Orleans Drive, Sunnyvale Ca 94089.

Discussions on Moshe Alafi

No discussions yet.